🔎 Trials Near Me

Home › Liver Cancer (Hepatocellular Carcinoma) › Arizona › Scottsdale

Liver Cancer (Hepatocellular Carcinoma) clinical trials in Scottsdale, AZ

7 studies for Liver Cancer (Hepatocellular Carcinoma) are looking for participants at sites in and around Scottsdale (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

RecruitingPhase 1/2
  • HonorHealth Research Institute, Scottsdale
Ages 18 to 75 · All sexes · Updated Aug 19, 2026 · NCT07636785

FOG-001 in Locally Advanced or Metastatic Solid Tumors

RecruitingPhase 1/2
  • Honor Health, Scottsdale
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264

Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer

RecruitingPhase 2
  • Mayo Clinic in Arizona, Scottsdale
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05168163

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

RecruitingPhase 4
  • Scottsdale Medical Imaging, LLC, Scottsdale
Ages 18 to 64 · All sexes · Updated Jan 22, 2026 · NCT04373564

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Scottsdale
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

RecruitingPhase 1
  • HonorHealth Research Institute, Scottsdale
Ages 18 and older · All sexes · Updated Feb 8, 2024 · NCT04282044

Liver Cancer (Hepatocellular Carcinoma) trials in other cities

Other studies in Scottsdale

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.